Great-West Lifeco Inc. (GWLIF) Stock Price & Analysis
Great-West Lifeco Inc. (GWLIF) is trading at USD 64.02, down 2.53% today, as of October 23, 2026 at 13:30 UTC (US market open; quotes may be delayed), according to Nexqual market data.
GWLIF last closed at USD 65.68; today's session has ranged USD 64.02–64.02 on volume of 60 shares. Market capitalization is $57.31B, with a 52-week range of USD 42.06–67.52 (PNK). Source: Nexqual, retrieved October 23, 2026 at 17:49 UTC.
Also available as compact Markdown for AI agents: nexqual.com/GWLIF.md
Key facts (GWLIF)
- Analysts: None.
- Total return with dividends: 1Y +60.7% vs S&P 500 +14.4%; 5Y +172.4% vs S&P 500 +77.1%.
- Next earnings: 2026-11-04, EPS estimate USD —, revenue estimate $0K.
Analysts (GWLIF)
Consensus None.
Total return (dividends reinvested) (GWLIF)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +60.7% | +172.4% |
| S&P 500 (SPY) | +14.4% | +77.1% |
| Per year | +60.9% | +22.2% |
| Volatility (annualized) | 26.8% | 21.5% |
| Max drawdown | -10.8% (Dec 2025→Feb 2026) | -31.2% (Jan 2022→Oct 2022) |
Companies that name GWLIF in their SEC reports
| Relationship to GWLIF | Company | Filing | Sentence |
|---|---|---|---|
| partner | FRANKLIN TEMPLETON INC (BEN) | 10-K Nov 10, 2025 | “We will pay up to $375.0 million related to our acquisition of Putnam between the third and seventh anniversaries of the closing date related to revenue growth targets from the strategic partnership with Great-West Lifeco, Inc. which will be recognized in operating income.” |
GWLIF analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year (ends Dec 2026) | — | — | — | $41.07B | — |
| Next fiscal year (ends Dec 2027) | — | — | — | $42.99B | — |
Key Statistics (as of October 23, 2026 at 17:49 UTC)
| Price | USD 64.02 |
|---|---|
| Change | ▼ 2.53% (down) |
| Previous Close | USD 65.68 |
| Open | USD 64.02 |
| Day Range | USD 64.02 – 64.02 |
| 52-Week Range | USD 42.06 – 67.52 |
| Volume | 60 shares |
| Market Cap | $57.31B |
| Exchange | PNK |
Technical Analysis (GWLIF)
Nexqual's technical model rates GWLIF "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 17:49 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.09 (neutral) |
| vs SMA50 | Below (USD 64.84) |
| MACD | -0.04 (negative) |
Analyst Ratings (GWLIF)
Wall Street analysts rate GWLIF "None", per Nexqual as of October 23, 2026 at 17:49 UTC.
| Consensus Rating | None |
|---|
Earnings (GWLIF)
| Next Earnings Date | 2026-11-04 |
|---|
Source: Nexqual, October 23, 2026 at 17:49 UTC.
Financials & Fundamentals (GWLIF)
| Total Revenue | $36.42B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +5.40% |
| Gross Margin | +47.93% |
| Operating Margin | +16.35% |
| Profit Margin | +12.72% |
| ROE | +14.13% |
| Debt / Equity | 0.26 |
| Current Ratio | 29.19 |
| Total Cash | $201.43B |
| Total Debt | $8.97B |
Source: Nexqual, October 23, 2026 at 17:49 UTC.
Financial Health Score (GWLIF)
Nexqual rates Great-West Lifeco Inc.'s overall financial health "Solid" across five dimensions, as of October 23, 2026 at 17:49 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 48%, operating 16% (last 12 months) |
| Balance Sheet | Strong — CAD 201.4B cash vs CAD 8.97B debt, net cash position |
| Cash Flow | Solid — Operating cash flow CAD 4.22B (TTM) |
| Efficiency | Mixed — ROE 14%, ROA 0.7% |
Ownership (GWLIF)
| Insider Ownership | +71.60% |
|---|---|
| Institutional Ownership | +10.19% |
| Shares Outstanding | 895.20M |
| Float | 282.44M |
Source: Nexqual, October 23, 2026 at 17:49 UTC.
Leadership (GWLIF)
Great-West Lifeco Inc. is led by David M. Harney, President, CEO & Director, per Nexqual as of October 23, 2026 at 17:49 UTC.
| President, CEO & Director | David M. Harney |
|---|---|
| EVP & CFO | Jon P. Nielsen |
| President & CEO of Empower | Edmund Francis Murphy |
| Senior Vice President of Corporate Finance & Treasury | Andrew Conrad |
Major Backers & Investors (GWLIF)
Notable institutional backers of Great-West Lifeco Inc. include AMERICAN FUNDS INSURANCE SERIES-Eupac Fund, Fidelity, TR PRICE-Price (T.Rowe) International Value Equity Trust, according to Nexqual as of October 23, 2026 at 17:49 UTC.
Active Investors
| Investor | Stake |
|---|---|
| AMERICAN FUNDS INSURANCE SERIES-Eupac Fund | 0.29% |
| Fidelity | 0.15% |
| TR PRICE-Price (T.Rowe) International Value Equity Trust | 0.13% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 0.74% |
| BlackRock | 0.16% |
Source: Nexqual, October 23, 2026 at 17:49 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AFL | AFLAC Incorporated | USD 120.61 | ▼ 2.16% |
| MET | MetLife, Inc. | USD 98.71 | ▼ 4.69% |
| MFC | Manulife Financial Corporation | USD 44.37 | ▼ 2.74% |
| PRU | Prudential Financial, Inc. | USD 114.74 | ▼ 2.9% |
| PUK | Prudential Public Limited Compa | USD 23.56 | ▼ 1.87% |
| UNM | Unum Group | USD 90.38 | ▼ 3.59% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 17:49 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt